Drug intelligence / Profile preview

potassium chloride + sodium acetate + magnesium chloride + sodium chloride + sodium gluconate

Development stage
Unknown
Lead developer
Baxter Healthcare Corporation
Modality
Small Molecules
Administration
Intravenous, Topical
01

Overview

**Potassium chloride + sodium acetate + magnesium chloride + sodium chloride + sodium gluconate** is a sterile, isotonic balanced multi-electrolyte solution used as an intravenous fluid replacement product and, in the Physiolyte presentation, as a sterile surgical irrigant. It supplies sodium, potassium, magnesium, chloride, acetate, and gluconate to restore extracellular fluid and electrolyte balance. Acetate and gluconate are metabolizable anions that consume hydrogen ions during metabolism, producing an alkalinizing effect. The composition is marketed by Baxter as Plasma-Lyte A and Plasma-Lyte 148 for intravenous administration and by B. Braun as Physiolyte for irrigation, washing, and rinsing; the Physiolyte label specifies that it is not for usual parenteral injection. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017378s068%2C017385s059lbl.pdf))

Brand names
Plasma-Lyte APlasma-Lyte 148Plasma-Lyte148Plasma-Lyte-148Physiolyte
Other names
multiple electrolytes injection type 1balanced electrolyte solutionphysiological irrigating solution

Beyond the preview

Go deeper on potassium chloride + sodium acetate + magnesium chloride + sodium chloride + sodium gluconate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on potassium chloride + sodium acetate + magnesium chloride + sodium chloride + sodium gluconate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call